𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms

✍ Scribed by Kiladjian, J-J; Chomienne, C; Fenaux, P


Book ID
109886646
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
168 KB
Volume
22
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


PEG-IFN-α-2b therapy in BCR-ABL–negative
✍ Elias Jabbour; Hagop Kantarjian; Jorge Cortes; Deborah Thomas; Guillermo Garcia- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract ## BACKGROUND. Interferon‐alpha (IFN‐α) has shown significant activity in the treatment of BCR‐ABL–negative myeloproliferative disorders (MPDs), particularly essential thrombocythemia (ET) and polycythemia vera (PV). PEG‐IFN‐α‐2b is a pegylated IFN‐α‐2b with a significant advantage ove

Genetic analysis of chromosome 13 deleti
✍ Cristina Pastore; Josep Nomdedeu; Gisella Volpe; Angelo Guerrasio; Giovanna Rege 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

## Abstract Chromosomal deletions of band 13q14 occur recurrently in __BCR/ABL__ negative chronic myeloproliferative disorders (CMPD), including myelosclerosis with myeloid metaplasia (MMM), polycythemia vera (PV), essential thrombocythemia (ET), juvenile chronic myeloid leukemia (JCML), and the so